Manuscripts
Showing 1459 manuscripts.
Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097
Citation
Diana F Clarke, Jos Lommerse, Edward P Acosta, Mae P Cababasay, Jiajia Wang, Stephen A Spector, Anne Chain, Elizabeth Smith, Hedy Teppler, Rohan Hazra, Kat Calabrese, Bobbie Graham, Stephanie Popson, Yvonne Bryson, Mark Mirochnick, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1097 Study Team. Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. Journal of Acquired Immune Deficiency Syndromes. 2021. 85: 626-634. PMID: 32925360Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1097
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children
Citation
Ruth A Karron, Jessica E Atwell, Elizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, Charlotte Perlowski, Jennifer Libous, Stephen A Spector, Ram Yogev, Mariam Aziz, Suzanne Woods, Kimberli Wanionek, Peter L Collins, Ursula J Buchholz. Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children. American Journal of Respiratory and Critical Care Medicine. 2021. PMID: 32871092Journal
American Journal of Respiratory and Critical Care Medicine
Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age
Citation
J C Lindsey, D L Jacobson, H Spiegel, C M Gordon, R Hazra, G K Siberry, IMPAACT P1076 Study Team. Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age. Clinical Infectious Diseases. 2021. PMID: 32584996Journal
Clinical Infectious Diseases
Study
P1076
Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV
Citation
Debika Bhattacharya, Rong Guo, Chi-Hong Tseng, Lynda Emel, Ren Sun, Shih-Hsin Chiu, Lynda Stranix-Chibanda, Tsungai Chipato, Neaka Mohtashemi, Kenneth Kintu, Karim Manji, Dhayendre Moodley, Chloe Thio, Yvonne Maldonado, Judith Currier. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV. Pediaric Infectious Disease Journal. 2021. PMID: 33181788Journal
Pediaric Infectious Disease Journal
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Citation
Theodore Ruel, Edmund Capparelli, Camlin Tierney, Bryan Nelson, Anne Coletti, Yvonne Bryson, Mark Cotton, Stephen Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh Naidoo, Rohan Hazra, Patrick Jean-Philippe, Ellen Chadwick. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021. PMID: 33242457Journal
Lancet HIV
Study
P1115
IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes ofImplementation
Citation
Jennifer Libous, Nicole A. Montañez, Geri R. Donenberg, Dorothy E. Dow, Suad Kapetanovic, Janice Buckley, Tebogo Jacqueline Kakhu, Portia Kamthunzi, Limbika A. Maliwichi, Tichaona Vhembo, Tariro Dianah Chawana, Teacler Nematadzira. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Frontiers in Reproductive Health. 2021. 3
Journal
Frontiers in Reproductive Health
Study
IMPAACT 2016
Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy
Citation
Engie Salama, Ahizechukwu C Eke, Brookie M Best, Mark Mirochnick, Jeremiah D Momper. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy. Journal of Clinical Pharmacology. 2021. 60: 1537-1550. PMID: 32798276Journal
Journal of Clinical Pharmacology
Study
P1026S
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development
Citation
Sherry Zhao, Mary Gockenbach, Manuela Grimstein, Hari Cheryl Sachs, Mark Mirochnick, Kimberly Struble, Yodit Belew, Jian Wang, Edmund B Capparelli, Brookie M Best, Tamara Johnson, Jeremiah D Momper, Anil R Maharaj. Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. Frontiers in Pediatrics. 2021. PMID: 34722417Journal
Frontiers in Pediatrics
Study
P1026S
Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV in the United States: Results from IMPAACT P1026s
Citation
Kristina M. Brooks, Mauricio Pinilla, Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV in the United States: Results from IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. PMID: 35195573Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S